Phenyltoloxamine citrate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C17H21NO.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8UE48MJH8M, chemically known as n,n-dimethyl-2-(alpha-phenyl-o-toloxy)ethylamine dihydrogen citrate but more generally known as phenyltoloxamine citrate, which bears US NIH Compound Identifier 14440. European Medicines Agency schedules Phenyltoloxamine citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03784MIG. Most nations, for tariff and trade purposes, schedule phenyltoloxamine citrate under HS 29221980 and SITC 51461. As of Q4 2014, PHENYLTOLOXAMINE CITRATE remains US FDA's Preferred Term for this commodity. Phenyltoloxamine citrate bears US NLM identifiers UMLS ID C0724662 and NCI Concept Code C82275. SMILES: CN(C)CCOC1CCCCC1CC2CCCCC2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.